
Kimberly Chong
Examiner (ID: 8669, Phone: (571)272-3111 , Office: P/1674 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1636, 1635, 1674 |
| Total Applications | 2007 |
| Issued Applications | 1153 |
| Pending Applications | 209 |
| Abandoned Applications | 674 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6064484
[patent_doc_number] => 20110201667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-08-18
[patent_title] => 'COMPOSITIONS AND METHODS FOR SILENCING EBOLA VIRUS GENE EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 12/840225
[patent_app_country] => US
[patent_app_date] => 2010-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 89117
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0201/20110201667.pdf
[firstpage_image] =>[orig_patent_app_number] => 12840225
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/840225 | Compositions and methods for silencing Ebola virus gene expression | Jul 19, 2010 | Issued |
Array
(
[id] => 7742422
[patent_doc_number] => 20120021035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-26
[patent_title] => 'Nanoparticles containing plymeric nucleic acid homologs, pharmaceutical composition and articles of manufacture containing same and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/804233
[patent_app_country] => US
[patent_app_date] => 2010-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 22130
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20120021035.pdf
[firstpage_image] =>[orig_patent_app_number] => 12804233
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/804233 | Nanoparticles containing plymeric nucleic acid homologs, pharmaceutical composition and articles of manufacture containing same and methods of use thereof | Jul 15, 2010 | Abandoned |
Array
(
[id] => 9009582
[patent_doc_number] => 08524880
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-03
[patent_title] => 'Antisense oligonucleotides for inducing exon skipping and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/837356
[patent_app_country] => US
[patent_app_date] => 2010-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 24
[patent_no_of_words] => 20774
[patent_no_of_claims] => 69
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12837356
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/837356 | Antisense oligonucleotides for inducing exon skipping and methods of use thereof | Jul 14, 2010 | Issued |
Array
(
[id] => 5993600
[patent_doc_number] => 20110015253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'ANTISENSE OLIGONUCLEOTIDES FOR INDUCING EXON SKIPPING AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/837359
[patent_app_country] => US
[patent_app_date] => 2010-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 20167
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12837359
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/837359 | Antisense oligonucleotides for inducing exon skipping and methods of use thereof | Jul 14, 2010 | Issued |
Array
(
[id] => 8300981
[patent_doc_number] => 20120183538
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-19
[patent_title] => 'SPARC ANTISENSE COMPOSITIONS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/382803
[patent_app_country] => US
[patent_app_date] => 2010-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 18323
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13382803
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/382803 | SPARC ANTISENSE COMPOSITIONS AND USES THEREOF | Jul 8, 2010 | Abandoned |
Array
(
[id] => 8465044
[patent_doc_number] => 20120270213
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-25
[patent_title] => 'SCREENING METHOD FOR CELL AGING'
[patent_app_type] => utility
[patent_app_number] => 13/382629
[patent_app_country] => US
[patent_app_date] => 2010-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 12832
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13382629
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/382629 | Screening method for cell aging | Jul 7, 2010 | Issued |
Array
(
[id] => 6236971
[patent_doc_number] => 20100267811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-21
[patent_title] => 'RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 12/825552
[patent_app_country] => US
[patent_app_date] => 2010-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 12965
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20100267811.pdf
[firstpage_image] =>[orig_patent_app_number] => 12825552
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/825552 | RNAi-RELATED INHIBITION OF TNFa SIGNALING PATHWAY FOR TREATMENT OF OCULAR ANGIOGENESIS | Jun 28, 2010 | Abandoned |
Array
(
[id] => 8197285
[patent_doc_number] => 20120121697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-05-17
[patent_title] => 'Compositions and Methods for the Diagnosis and Treatment of Inflammatory Disorders and Fibrotic Disease'
[patent_app_type] => utility
[patent_app_number] => 13/380320
[patent_app_country] => US
[patent_app_date] => 2010-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 25054
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0121/20120121697.pdf
[firstpage_image] =>[orig_patent_app_number] => 13380320
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/380320 | Compositions and methods for the diagnosis and treatment of inflammatory disorders and fibrotic disease | Jun 23, 2010 | Issued |
Array
(
[id] => 10898116
[patent_doc_number] => 08921330
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-12-30
[patent_title] => 'Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene'
[patent_app_type] => utility
[patent_app_number] => 13/379743
[patent_app_country] => US
[patent_app_date] => 2010-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 26681
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13379743
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/379743 | Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene | Jun 23, 2010 | Issued |
Array
(
[id] => 4629387
[patent_doc_number] => 08008273
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-30
[patent_title] => 'SHIP-deficiency to increase megakaryocyte progenitor production'
[patent_app_type] => utility
[patent_app_number] => 12/819711
[patent_app_country] => US
[patent_app_date] => 2010-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 19
[patent_no_of_words] => 27593
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/008/08008273.pdf
[firstpage_image] =>[orig_patent_app_number] => 12819711
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/819711 | SHIP-deficiency to increase megakaryocyte progenitor production | Jun 20, 2010 | Issued |
Array
(
[id] => 6126715
[patent_doc_number] => 20110086425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-14
[patent_title] => 'DELIVERY OF siRNAs'
[patent_app_type] => utility
[patent_app_number] => 12/818228
[patent_app_country] => US
[patent_app_date] => 2010-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 10461
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20110086425.pdf
[firstpage_image] =>[orig_patent_app_number] => 12818228
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/818228 | DELIVERY OF siRNAs | Jun 17, 2010 | Abandoned |
Array
(
[id] => 7663964
[patent_doc_number] => 20110313233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'DOWN-REGULATION OF COLD SHOCK PROTEINS FOR CANCER TREATMENT'
[patent_app_type] => utility
[patent_app_number] => 12/817448
[patent_app_country] => US
[patent_app_date] => 2010-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 14984
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0313/20110313233.pdf
[firstpage_image] =>[orig_patent_app_number] => 12817448
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/817448 | DOWN-REGULATION OF COLD SHOCK PROTEINS FOR CANCER TREATMENT | Jun 16, 2010 | Abandoned |
Array
(
[id] => 6583227
[patent_doc_number] => 20100291194
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'Compositions and Methods for Inhibiting Expression of a Mutant Gene'
[patent_app_type] => utility
[patent_app_number] => 12/817009
[patent_app_country] => US
[patent_app_date] => 2010-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10239
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20100291194.pdf
[firstpage_image] =>[orig_patent_app_number] => 12817009
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/817009 | Compositions and methods for inhibiting expression of a mutant gene | Jun 15, 2010 | Issued |
Array
(
[id] => 4471191
[patent_doc_number] => 07943756
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-05-17
[patent_title] => 'Anti-microRNA oligonucleotide molecules'
[patent_app_type] => utility
[patent_app_number] => 12/794085
[patent_app_country] => US
[patent_app_date] => 2010-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11848
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/943/07943756.pdf
[firstpage_image] =>[orig_patent_app_number] => 12794085
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/794085 | Anti-microRNA oligonucleotide molecules | Jun 3, 2010 | Issued |
Array
(
[id] => 5944973
[patent_doc_number] => 20110105593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'MicroRNA-Formatted Multitarget Interfering RNA Vector Constructs and Methods of Using The Same'
[patent_app_type] => utility
[patent_app_number] => 12/793248
[patent_app_country] => US
[patent_app_date] => 2010-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 13661
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20110105593.pdf
[firstpage_image] =>[orig_patent_app_number] => 12793248
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/793248 | MicroRNA-Formatted Multitarget Interfering RNA Vector Constructs and Methods of Using The Same | Jun 2, 2010 | Abandoned |
Array
(
[id] => 7683677
[patent_doc_number] => 20100240734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-23
[patent_title] => 'METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA'
[patent_app_type] => utility
[patent_app_number] => 12/791369
[patent_app_country] => US
[patent_app_date] => 2010-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 31457
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0240/20100240734.pdf
[firstpage_image] =>[orig_patent_app_number] => 12791369
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/791369 | METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF GENE EXPRESSION BY DOUBLE-STRANDED RNA | May 31, 2010 | Abandoned |
Array
(
[id] => 8265968
[patent_doc_number] => 20120165392
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-06-28
[patent_title] => 'Identification of Micro-RNAS Involved in Post-Myocardial Infarction Remodeling and Heart Failure'
[patent_app_type] => utility
[patent_app_number] => 13/321756
[patent_app_country] => US
[patent_app_date] => 2010-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22184
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13321756
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/321756 | Identification of micro-RNAs involved in post-myocardial infarction remodeling and heart failure | May 19, 2010 | Issued |
Array
(
[id] => 6619214
[patent_doc_number] => 20100324119
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-23
[patent_title] => 'REDUCING IRF4, DUSP22, OR FLJ43663 POLYPEPTIDE EXPRESSION'
[patent_app_type] => utility
[patent_app_number] => 12/782484
[patent_app_country] => US
[patent_app_date] => 2010-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 15577
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20100324119.pdf
[firstpage_image] =>[orig_patent_app_number] => 12782484
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/782484 | REDUCING IRF4, DUSP22, OR FLJ43663 POLYPEPTIDE EXPRESSION | May 17, 2010 | Abandoned |
Array
(
[id] => 7784680
[patent_doc_number] => 20120046236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-23
[patent_title] => 'TREATMENT OF TRISTETRAPROLINE (TTP) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO TTP'
[patent_app_type] => utility
[patent_app_number] => 13/318700
[patent_app_country] => US
[patent_app_date] => 2010-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 24856
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0046/20120046236.pdf
[firstpage_image] =>[orig_patent_app_number] => 13318700
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/318700 | TREATMENT OF TRISTETRAPROLINE (TTP) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO TTP | May 5, 2010 | Abandoned |
Array
(
[id] => 9009581
[patent_doc_number] => 08524879
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-03
[patent_title] => 'RNA interference suppresion of neurodegenerative diseases and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 12/774019
[patent_app_country] => US
[patent_app_date] => 2010-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 47
[patent_no_of_words] => 30524
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12774019
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/774019 | RNA interference suppresion of neurodegenerative diseases and methods of use thereof | May 4, 2010 | Issued |